Molecular and functional investigation of the role of CD1 in gamma delta T cell surveillance
CD1 在 γ δ T 细胞监测中作用的分子和功能研究
基本信息
- 批准号:10268214
- 负责人:
- 金额:$ 52.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-22 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAnti-Inflammatory AgentsAntigensAutoimmunityBindingBiochemicalBiochemistryBiological AssayBiophysicsCD1 AntigensCancerousCell Culture TechniquesCell LineCell physiologyCellsClonal ExpansionColonColorectal CancerComplementComplexCrystallizationDataDiseaseEnsureEpithelialFoundationsFrequenciesGenerationsGlycoproteinsGoalsHealthHumanImmune responseImmunityImmunobiologyIn VitroIndividualInfectionInfectious AgentInflammatoryInstitutional Review BoardsInvestigationLaboratoriesLeadLigandsLinkLipidsMajor Histocompatibility ComplexMalignant NeoplasmsMediatingMemoryMolecularMusPeripheralPhenotypePhysiologicalPlayPopulationProtein BiochemistryProtein EngineeringRNARoleSamplingShapesSignal TransductionSpecificityStressStructureSulfoglycosphingolipidsSystemT-Cell ActivationT-Cell ReceptorT-LymphocyteT-cell receptor repertoireTestingTissuesTranscriptTumor-DerivedUmbilical Cord BloodViralWorkX-Ray Crystallographyadaptive immune responseantigen detectionbiophysical analysiscell growthcolorectal cancer progressioncytokinefunctional statushuman diseaseimmunoregulationinnovationinsightinterestpathogenperipheral bloodpremalignantprofessorreceptorreceptor bindingrecruitresponsestructural biologysuccesstooltranscriptome sequencingtumortumor microenvironmenttumorigenesisγδ T cells
项目摘要
γδ T cells constitute an important component of the immune response against infectious agents and cancerous
transformations, yet the biochemical mechanisms by which they detect antigen through their somatically
recombined T cell receptor (TCR) remain unclear. Unlike αβTCRs, which are restricted to recognizing antigens
in the context of Major Histocompatibility Complex (MHC) molecules, γδTCRs can recognize a diversity of ligands
ranging from self MHC to intact, unprocessed, viral glycoproteins. Our recent work has established CD1
molecules as ligands for a subpopulation of human Vδ1 γδ T cells, producing robust functional, biochemical and
structural evidence. We seek to extend our studies to the human gut, where γδ T cells, and in particular, Vδ1+
T cells, predominate. Our preliminary data suggests that CD1 recognition is robust and present in all individuals
examined, and that there exist important functional differences between CD1 reactive γδ T cells in tumors versus
healthy adjoining tissue. Thus, the long-term goal of this proposal is to fully characterize this CD1 reactive
population in tumors versus healthy tissue, examining their functional effector phenotypes, TCR repertoire and
immunomodulatory signals, in addition to the TCR, that shape the recruitment, activation and potential expansion
of these cells in the context of a highly relevant human disease, colorectal cancer. Our first aim,
“Characterization of CD1-specific γδ T cells in normal and diseased tissue.”, seeks to use classical cellular
expansions complemented by direct ex vivo functional and transcript analysis to profile CD1 reactive and non-
reactive T cell populations derived from tumor and adjoining healthy tissue. These data will provide insight into
the signals that regulate γδ T cells within the tumor microenvironment compared to healthy tissue. Our second
aim, “Elucidation of the molecular mechanisms by which γδ TCRs bind to CD1/lipid complexes.”, will
focus on characterizing the interaction between the γδ TCRs expressed by these cells and CD1/lipid antigen.
We will use protein biochemistry, biophysics and x-ray crystallography to elucide the molecular mechanisms by
which the γδ TCR recognizes CD1/lipid. Our effort will significantly expand our understanding of the specific
signals that regulate γδ T cell activity in human health and disease. Our third aim, “Determine the presence
and role of ligand, co-stimulatory and/or co-receptor molecules in CD1 specific γδ T cell activation and
phenotype in the colon” will characterize the ligand and immunomodulatory signals that may regulate the
activity of CD1 reactive γδ T cells in the context of human colorectal cancer. We will combine RNAseq and
differentiation assays using cord blood derived, naïve Vδ1 cells to test the relevance of candidate signals. This
will be complemented by in vitro derived native Vδ1 T cells through the OP9/DL1 system. γδ T cells can be either
pro-inflammatory or regulatory, therefore we seek to understand which role these cells play, if any, in this disease
state. Together, these aims will begin to unravel the mystery of γδ T cells in human immunobiology, both at the
cellular and molecular levels.
γδT细胞是机体对感染性物质和癌症免疫反应的重要组成部分
转化,然而,他们通过其躯体检测抗原的生化机制
重组T细胞受体(TCR)仍不清楚。与αβTCR不同,TCR仅限于识别抗原
在主要组织相容性复合体(MHC)分子的背景下,γδTCR可以识别多种配体
从自身的MHC到完整的、未加工的病毒糖蛋白。我们最近的工作已经建立了CD1
分子作为人类Vδ1γδT细胞亚群的配体,产生强大的功能、生化和
结构性证据。我们试图将我们的研究扩展到人类肠道,在那里γδT细胞,特别是Vδ1+
T细胞占优势。我们的初步数据表明,CD1的识别能力很强,在所有个体中都存在
研究表明,肿瘤中CD1反应性γδT细胞与
健康的邻近组织。因此,这项提议的长期目标是充分描述CD1的反应性
在肿瘤和健康组织中的人群,检查他们的功能效应表型,TCR谱系和
免疫调节信号,除TCR外,还影响募集、激活和潜在的扩张
这些细胞与一种高度相关的人类疾病--结直肠癌有关。我们的第一个目标,
《正常和疾病组织中CD1特异性γδT细胞的特征》,试图用经典的细胞学
扩增辅以直接体外功能和转录分析以分析CD1反应性和非反应性
来自肿瘤和邻近健康组织的反应性T细胞群。这些数据将提供对
与健康组织相比,在肿瘤微环境中调节γδT细胞的信号。我们的第二个
目的:《阐明CD1TCRs与γδ/脂质复合体结合的分子机制》,Will
重点研究这些细胞表达的CD1TCR与γδ/脂类抗原之间的相互作用。
我们将利用蛋白质生物化学、生物物理学和x射线结晶学来阐明其分子机制。
其中CD1TCR识别γδ/脂质。我们的努力将大大扩大我们对具体情况的理解
调节人类健康和疾病中γδT细胞活动的信号。我们的第三个目标,“确定存在”
配体、共刺激和/或共受体分子在CD1特异性γδT细胞激活和/或激活中的作用
结肠的表型“将表征配体和免疫调节信号,这些信号可能调节
CD1反应性γδT细胞在人类结直肠癌中的活性我们将结合RNAseq和
分化试验使用脐带血来源的幼稚Vδ1细胞来检验候选信号的相关性。这
将通过OP9DL1系统得到体外来源的天然Vδ1T细胞的补充。γδT细胞可以是
促炎性或调节性,因此我们试图了解这些细胞在这种疾病中起什么作用,如果有的话。
州政府。这些目标加在一起,将开始揭开人类免疫生物学中γδT细胞的神秘面纱
细胞和分子水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erin June Adams其他文献
Erin June Adams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erin June Adams', 18)}}的其他基金
Investigation into the Endogenous Ligand Repertoire of the Non-Classical MHC-Related Protein, MR1 in Multiple Myeloma Cell Lines
多发性骨髓瘤细胞系中非经典 MHC 相关蛋白 MR1 内源配体库的研究
- 批准号:
10557884 - 财政年份:2022
- 资助金额:
$ 52.47万 - 项目类别:
Molecular and functional investigation of the role of HLA-F in immune regulation
HLA-F在免疫调节中作用的分子和功能研究
- 批准号:
10503676 - 财政年份:2022
- 资助金额:
$ 52.47万 - 项目类别:
Molecular and functional investigation of the role of HLA-F in immune regulation
HLA-F在免疫调节中作用的分子和功能研究
- 批准号:
10636894 - 财政年份:2022
- 资助金额:
$ 52.47万 - 项目类别:
Investigation into the Endogenous Ligand Repertoire of the Non-Classical MHC-Related Protein, MR1 in Multiple Myeloma Cell Lines
多发性骨髓瘤细胞系中非经典 MHC 相关蛋白 MR1 内源配体库的研究
- 批准号:
10452305 - 财政年份:2022
- 资助金额:
$ 52.47万 - 项目类别:
Determining the Origins of Nonclassical Class I molecules through Molecular and Functional Approaches
通过分子和功能方法确定非经典 I 类分子的起源
- 批准号:
10501472 - 财政年份:2022
- 资助金额:
$ 52.47万 - 项目类别:
Determining the Origins of Nonclassical Class I molecules through Molecular and Functional Approaches
通过分子和功能方法确定非经典 I 类分子的起源
- 批准号:
10645114 - 财政年份:2022
- 资助金额:
$ 52.47万 - 项目类别:
Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory
为 Howard T. Ricketts 生物防护实验室提供设施和建筑系统升级支持
- 批准号:
10394614 - 财政年份:2021
- 资助金额:
$ 52.47万 - 项目类别:
Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory
为 Howard T. Ricketts 生物防护实验室提供设施和建筑系统升级支持
- 批准号:
10631368 - 财政年份:2021
- 资助金额:
$ 52.47万 - 项目类别:
Molecular and functional investigation of the role of CD1 in gamma delta T cell surveillance
CD1 在 γ δ T 细胞监测中作用的分子和功能研究
- 批准号:
10670830 - 财政年份:2020
- 资助金额:
$ 52.47万 - 项目类别:
Molecular and functional investigation of the role of CD1 in gamma delta T cell surveillance
CD1 在 γ δ T 细胞监测中作用的分子和功能研究
- 批准号:
10462661 - 财政年份:2020
- 资助金额:
$ 52.47万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 52.47万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 52.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 52.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 52.47万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 52.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 52.47万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 52.47万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 52.47万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 52.47万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 52.47万 - 项目类别:
Standard Grant